Legal & General Group Plc Decreases Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

featured-image

Legal & General Group Plc cut its holdings in Select Medical Holdings Co. (NYSE:SEM – Free Report) by 3.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 307,661 shares of the health services provider’s stock after selling 9,888 shares during the [...]

Legal & General Group Plc cut its holdings in Select Medical Holdings Co. (NYSE:SEM – Free Report) by 3.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

The fund owned 307,661 shares of the health services provider’s stock after selling 9,888 shares during the quarter. Legal & General Group Plc owned approximately 0.24% of Select Medical worth $5,799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).



Other hedge funds also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Select Medical in the 4th quarter worth approximately $29,556,000. Invesco Ltd.

boosted its holdings in Select Medical by 48.6% in the fourth quarter. Invesco Ltd.

now owns 2,643,943 shares of the health services provider’s stock valued at $49,838,000 after acquiring an additional 864,852 shares in the last quarter. Empowered Funds LLC purchased a new position in Select Medical during the 4th quarter valued at $5,903,000. Raymond James Financial Inc.

purchased a new stake in shares of Select Medical in the 4th quarter worth about $5,858,000. Finally, Barclays PLC boosted its stake in shares of Select Medical by 396.0% during the 3rd quarter.

Barclays PLC now owns 192,357 shares of the health services provider’s stock valued at $6,707,000 after purchasing an additional 153,576 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Price PerformanceSEM opened at $16.35 on Monday. The firm has a market cap of $2.

11 billion, a PE ratio of 9.91, a P/E/G ratio of 0.64 and a beta of 1.

38. The stock has a 50-day moving average price of $17.27 and a 200-day moving average price of $22.

83. Select Medical Holdings Co. has a 1 year low of $14.

99 and a 1 year high of $40.98. The company has a debt-to-equity ratio of 1.

37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM – Get Free Report) last issued its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.

29 by ($0.11). The firm had revenue of $1.

31 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Select Medical had a return on equity of 14.

04% and a net margin of 3.23%. Sell-side analysts predict that Select Medical Holdings Co.

will post 1.17 earnings per share for the current fiscal year. Select Medical Cuts DividendThe business also recently declared a quarterly dividend, which was paid on Thursday, March 13th.

Stockholders of record on Monday, March 3rd were paid a $0.0625 dividend. The ex-dividend date of this dividend was Monday, March 3rd.

This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.53%.

Select Medical’s dividend payout ratio is presently 15.15%. Wall Street Analysts Forecast GrowthSeveral brokerages have commented on SEM.

StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Mizuho initiated coverage on Select Medical in a research report on Wednesday, April 16th.

They set an “outperform” rating and a $25.00 price target on the stock. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.

00 price objective for the company in a report on Monday, February 24th. UBS Group dropped their target price on shares of Select Medical from $40.00 to $21.

00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, Royal Bank of Canada lowered their price target on shares of Select Medical from $47.00 to $23.

00 and set an “outperform” rating for the company in a research report on Monday, February 24th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $26.

80.Check Out Our Latest Report on SEMSelect Medical Profile (Free Report)Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further ReadingFive stocks we like better than Select MedicalInvesting in the High PE Growth Stocks With a 60%+ Upside, There’s Plenty to Love About LovesacHow Can Investors Benefit From After-Hours TradingJ.B. Hunt Transport Overcorrects Into a Buying OpportunityGrowth Investing: Should You Adopt This Investing Strategy in 2022?AppLovin: Can Record Profits Overcome Market Skepticism?Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report)..